Allison Kassir
🏛️ Revolving DoorFormer Government Position:
Staff, Rep. McHale, OSD/DOD & House Armed Services Committee
🤖
AI Overview
Allison Kassir has appeared in 526 federal lobbying filings at King & Spalding LLP, representing 48 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 18 policy areas.
526
Total Filings
1
Firms
48
Clients
18
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 44 | 12 |
| 2019 | 45 | 18 |
| 2020 | 54 | 16 |
| 2021 | 93 | 25 |
| 2022 | 84 | 22 |
| 2023 | 83 | 20 |
| 2024 | 65 | 20 |
| 2025 | 58 | 22 |
Firms
King & Spalding LLP526 filings
Top Clients
American College of Medical Genetics32 filings
Adventist Healthcare31 filings
Multicare Health System31 filings
Marc Coalition30 filings
Senior Care Pharmacy Coalition29 filings
Seaboard Corporation28 filings
Comcast Corporation20 filings
The City of Miami, Florida19 filings
Kaneka Pharma America, LLC18 filings
Genentech, INC.18 filings
Padron Cigars17 filings
Becton, Dickinson and Company16 filings
Honduras Prospera INC.15 filings
National League of Cities14 filings
Amarin Pharma, INC.13 filings
Transmedics, INC.13 filings
Flagler Health +12 filings
Audentes Therapeutics11 filings
Henry Schein INC11 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
The Crypto Lobbying Explosion
How crypto went from zero to massive lobbying presence.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.